What is the recommended dosage of amoxicillin (amox) for pediatric patients with sinusitis in mg/kg/day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for Pediatric Sinusitis

For pediatric patients with acute bacterial sinusitis, the recommended amoxicillin dosage is 45 mg/kg/day divided into two doses (BID), or 90 mg/kg/day divided into two doses for high-dose therapy when antibiotic resistance is suspected or the child is at high risk. 1, 2

Standard vs High-Dose Regimens

Standard-Dose Amoxicillin

  • 45 mg/kg/day divided BID is appropriate for uncomplicated acute bacterial sinusitis in children without risk factors for resistant organisms 1
  • This dosing provides adequate coverage for susceptible Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 3

High-Dose Amoxicillin

  • 90 mg/kg/day divided BID (maximum 1 gram every 12 hours) is recommended when penicillin-resistant S. pneumoniae is suspected 1, 2
  • This higher dose overcomes resistance mediated by altered penicillin-binding proteins in approximately 25-50% of S. pneumoniae strains 1
  • The increased dose achieves sinus fluid concentrations adequate to eradicate resistant organisms 2

Risk Factors Requiring High-Dose Therapy

High-dose amoxicillin (90 mg/kg/day) should be used for children with: 2

  • Age younger than 2 years (higher risk for harboring resistant organisms)
  • Recent antibiotic exposure within the previous 30 days
  • Severe infection at presentation
  • Daycare attendance or other risk factors for resistant pathogens

Amoxicillin-Clavulanate (Augmentin) Considerations

When β-lactamase-producing organisms are suspected:

  • Amoxicillin-clavulanate 80-90 mg/kg/day (based on amoxicillin component) with 6.4 mg/kg/day clavulanate in 2 divided doses 1, 2
  • This formulation provides coverage against β-lactamase-producing H. influenzae and M. catarrhalis, which represent nearly 50% and 90-100% of isolates respectively in most geographic areas 1
  • The clavulanate component is essential for β-lactamase-producing pathogens 2

Treatment Duration and Monitoring

  • 10-14 days is the standard treatment duration 2, 3
  • Some guidelines recommend continuing until 7 days after symptom resolution 2
  • Reassess at 3-5 days: if no clinical improvement, consider changing antibiotics or reevaluating the diagnosis 2

Alternative Dosing from Older Guidelines

An older guideline from 2005 listed amoxicillin at 45 mg/kg BID for pediatric sinusitis 1, but this has been superseded by more recent recommendations emphasizing 90 mg/kg/day for high-risk patients 2, 3. The evolution reflects increasing antibiotic resistance patterns.

Important Caveats

  • First-generation cephalosporins, macrolides, and trimethoprim-sulfamethoxazole are no longer recommended due to high resistance rates 1
  • For children unable to tolerate oral medication, ceftriaxone 50 mg/kg IV/IM can be given as a single dose, with transition to oral therapy if improvement occurs at 24 hours 2
  • One placebo-controlled trial found no benefit of amoxicillin 40 mg/kg/day over placebo 4, but this used suboptimal dosing by current standards and highlights the importance of adequate dosing for resistant organisms

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Augmentin Dosing for Pediatric Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.